That the Parliament recognises that November is Lung Cancer Awareness Month; understands that lung cancer is the most common cancer in Scotland and that there are more than twice as many cases in the most deprived areas as there are in the least deprived areas of the country; believes that there are around 4,000 lung cancer deaths in Scotland every year; welcomes Cancer Research UK-funded research into new ways of diagnosing lung cancer using technologies like AI and blood tests that can detect tumour DNA, which Cancer Research UK helped pioneer through the TRACERx study; recognises that, in September 2022, the UK National Screening Committee (UK NSC) formally announced its recommendation that targeted lung screening is implemented for people aged 55 to 74 with a history of smoking across the UK; understands that lung cancer screening aims to find lung cancer at an early stage, when treatment is more likely to be successful; notes the calls from Cancer Research UK for the urgent roll-out of a national targeted lung cancer screening programme in Scotland; acknowledges the commitment in the Cancer Strategy for Scotland 2023 to 2033 to take forward the UK NSC recommendation on targeted lung screening, and notes Cancer Research UK’s call for the Scottish Government to make a commitment to rolling out a national targeted lung cancer screening programme, including investment to tackle shortages in the workforce and diagnostic equipment, to ensure that everyone who needs it can benefit.